Issues in setting health-based cleanup levels for arsenic in soil

Regulatory Toxicology and Pharmacology

Volumn 26, Issue 2, 1997, Pages 219-229

  Valberg, P A ^a   Beck, B D ^a   Bowers, T S ^a   Keating, J L ^a   Bergstrom, P D ^b   Boardman, P D ^c  

^a GRADIENT   (United States)

^b Rust Environment and Infrastructure   (United States)

^c CARO RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER;

BIOAVAILABILITY; CARCINOGENESIS; HEALTH HAZARD; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOIL POLLUTION; WATER CONTAMINATION;

ANIMALIA;

EID: 0030778113     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1997.1148     Document Type: Article

References (51)

1. Agency for Toxic Substances and Disease Registry (ATSDR), 1993, Toxicological Profile for Arsenic, ATSDR, Atlanta, GA.
2. Baker E. L. Jr., Hayes C. G., Landrigan P. J., Handke J. L., Leger R. T., Houseworth W. J., Harrington J. M. A nationwide survey of heavy metal absorption in children living near primary copper, lead, and zinc smelters. Am. J. Epidemiol. 106:1977;261-273.
3. Beck B. D., Boardman P. D., Hook G. C., Rudel R. A., Slayton T. M., Carlson-Lynch H. Correspondence: Response to Smithet al. Environ. Health Perspect. 103:1995;15-16.
4. S. Binder, 1987, Mill Creek pre- and post-move urinary-arsenic levels.
5. Binder S., Forney D., Kaye W., Paschal D. Arsenic exposure in children living near a former copper smelter. Bull. Environ. Contam. Toxicol. 39:1987;114-121.
6. Borum D. R., Abernathy C. O. Human oral exposure to inorganic arsenic. Arsenic. Exposure and Health. 1994;Science and Technology Letters, Northwood. p. 21-29.
7. Buchet J. P., Lauwerys R., Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int. Arch. Occup. Environ. Health. 48:1981;111-118.
8. Butte-Silver Bow Department of Health and University of Cincinnati Department of Environmental Health, 1992, The Butte-Silver Bow County Environmental Health Lead Study.
9. Carlson-Lynch H., Beck B. D., Boardman P. D. Arsenic risk assessment: A commentary. Environ. Health Perspect. 102:1994;354-356.
10. Chen C.-J., Chuang Y.-C., Lin T.-M., Wu H.-Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res. 45:1985;5895-5899.
11. Colorado Department of Health Division of Disease Control and Environmental Epidemiology, University of Colorado at Denver, Center for Environmental Sciences, and Agency for Toxic Substances and Disease Registry (ATSDR), 1990, Leadville Metals Exposure Study, State of Colorado.
12. Dabeka R. W., McKenzie A. D., Lacroix G. M. A., Cleroux C., Bowe S., Graham R. A., Conacher H. B. S., Verdier P. Survey of arsenic in total diet food composites and estimation of the dietary intake of arsenic by Canadian adults and children. J. AOAC Int. 76:1993;14-25.
13. Davis A., Ruby M. V., Bergstrom P. D. Bioavailability of arsenic and lead in soils from the Butte, Montana, mining district. Environ. Sci. Technol. 26:1992;461-468.
14. Dragun J., Chiasson A. Elements in North American Soils. 1991;Hazardous Materials Control Resources Institute, Greenbelt. p. 26-31.
15. Freeman G. B., Johnson J. D., Killinger J. M., Liao S. C., Davis A. O., Ruby M. V., Chaney R. L., Lovre S. C., Bergstrom P. D. Bioavailability of arsenic in soil impacted by smelter activities following oral administration in rabbits. Fundam. Appl. Toxicol. 21:1993;83-88.
16. Freeman G. B., Schoof R. A., Ruby M. V., Davis A. O., Dill J. A., Liao S. C., Lapin C. A., Bergstrom P. D. Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys. Fundam. Appl. Toxicol. 28:1995;215-222.
17. Griffin S., Turck P. Bioavailability in rabbits of sodium arsenite adsorbed to soils. Toxicologist. 11:1991;195.
18. Groen K., Vaessen H. A. M. G., Kliest J. J. G., de Boer J. L. M., van Ooik T., Timmerman A., Vlug R. F. Bioavailability of inorganic arsenic from bog ore-containing soil in the dog. Environ. Health Perspect. 102:1994;182-184.
19. Hewitt D. J., Millner G. C., Nye A. C., Webb M., Huss R. G. Evaluation of residential exposure to arsenic in soil near a Superfund site. Hum. Ecol. Risk Assessment. 1:1995;323-335.
20. Hinds W., First M. W., Huber G. L., Shea J. W. A method for measuring respiratory deposition of cigarette smoke during smoking. Am. Ind. Hyg. Assoc. J. 44:1983;113-118.
21. Hwang Y.-H., Bornschein R. L., Grote J., Menrath W., Roda S. Environmental arsenic exposure of children around a former copper smelter site. Environ. Res. 72:1997;72-81.
22. International Commission on Radiological Protection (ICRP), 1975, Report of the Task Group on Reference Man, Pergamon Press, Elmsford, NY.
23. Johnson L. R., Farmer J. G. Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure. Bull. Environ. Contam. Toxicol. 46:1991;53-61.
24. Klaassen C. D., Amdur M. O., Doull J. Casarett and Doull's Toxicology. The Basic Science of Poisons. 1996;Macmillan, New York. p. 697-.
25. Lide D. R. CRC Handbook of Chemistry and Physics 71st Edition 1990-1991. 1990;CRC Press, Boca Raton.
26. Mann S., Droz P.-O., Vahter M. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol. Appl. Pharmacol. 140:1996;471-486.
27. Menzel D. B., Ross M., Oddo S. V., Bergstrom P., Greene H., Roth R. N. A physiologically based pharmacokinetic model for ingested arsenic. Chappell W. R., Abernathy C. O., Cothern C. R. Arsenic. Exposure and Health. 1994;209-218 Science and Technology Letters, Northwood.
28. Mohri T., Hisanaga A., Ishinishi N. Arsenic intake and excretion by Japanese adults: A 7-day duplicate diet study. Food Chem. Toxicol. 28:1990;521-529.
29. Mushak P., Crocetti A. F. Commentary: Risk and revisionism in arsenic cancer risk assessment. Environ. Health Perspect. 103:1995;684-689.
30. Mushak P., Crocetti A. F. Correspondence - Response: Accuracy, arsenic, and cancer. Environ. Health Perspect. 104:1996;1014-1018.
31. Oklahoma Department of Environmental Quality (ODEQ), 1994, Record of Decision for Operable Unit One of the National Zinc Site.
32. Polissar L., Lowry-Coble K., Kalman D. A., Hughes J. P., van Belle G., Covert D. S., Burbacher T. M., Bolgiano D., Mottet N. K. Pathways of human exposure to arsenic in a community surrounding a copper smelter. Environ. Res. 53:1990;29-47.
33. Ruby M. V., Davis A., Schoof R., Eberle S., Sellstone C. M. Estimation of lead and arsenic bioavailability using a physiologically-based extraction test. Environ. Sci. Technol. 30:1996;422-426.
34. Slayton T. M., Beck B. D., Reynolds K. A., Chapnick S. D., Valberg P. A., Yost L. J., Schoof R. A., Gauthier T. D., Jones L. Correspondence: Issues in arsenic cancer risk assessment. Environ. Health Perspect. 104:1996;1012-1013.
35. Smith A. H., Biggs M.-L., Hopenhayn-Rich C., Kalman D. Correspondence: Arsenic risk assessment. Environ. Health Perspect. 103:1995;13-15.
36. Thompson D. J. Review article: A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 88:1993;89-114.
37. Tseng W. P., Chu H. M., How S. W., Fong J. M., Lin C. S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40:1968;453-463.
38. U.S. Environmental Protection Agency (USEPA), 1988, Special Report on Ingested Inorganic Arsenic - Skin Cancer: Nutritional Essentiality.
39. U.S. Environmental Protection Agency (USEPA), 1990, Superfund Record of Decision: Myers Property, NJ.
40. U.S. Environmental Protection Agency (USEPA), 1992, ROD Annual Report FY 1991.
41. U.S. Environmental Protection Agency (USEPA), 1993a, ROD Annual Report FY 1992.
42. U.S. Environmental Protection Agency (USEPA), 1993b, Superfund Record of Decision: Commencement Bay - Nearshore/Tideflats, WA, Region 10, Seattle, WA.
43. U.S. Environmental Protection Agency (USEPA), 1993c, Draft Drinking Water Criteria Document on Arsenic, Life Systems, Inc.
44. U.S. Environmental Protection Agency (USEPA), 1994, Superfund Record of Decision: Old Works/East Anaconda Development Area Operable Unit, Anaconda Smelter NPL Site, Anaconda, Montana, Region VIII, Helena, MT.
45. U.S. Environmental Protection Agency (USEPA), 1996a, Soil Screening Guidance: Technical Background Document.
46. U.S. Environmental Protection Agency (USEPA), 1996b, Record of Decision: Community Soils Operable Unit, Anaconda Smelter NPL Site, Anaconda, Montana, Region VIII and Montana Department of Environmental Quality, Helena, MT.
47. U.S. Environmental Protection Agency (USEPA), 1997, Integrated Risk Information System (IRIS).Record for Arsenic, Office of Health and Environmental Assessment, Cincinnati, OH.
48. Vahter M. Review: Species differences in the metabolism of arsenic compounds. Appl. Organometallic Chem. 8:1994;175-182.
49. Valberg P. A., Beck B. D., Boardman P. D., Cohen J. T. Likelihood ratio analysis of skin cancer prevalence associated with arsenic in drinking water in the U.S. Environ. Geochem. Health. 1998.
50. Valentine J. L., Kang H. K., Spivey G. Arsenic levels in human blood, urine, and hair in response to exposure via drinking water. Environ. Res. 20:1979;24-32.
51. Wong O., Whorton M. D., Foliart D. E., Lowengart R. An ecologic study of skin cancer and environmental arsenic exposure. Int. Arch. Occup. Environ. Health. 64:1992;235-241.